Andreas Billich

8.7k citations
131 papers · 6.8k · 1 hit paper · h-index 42

Impact in

  • Virology top 1%
    • HIV Research and Treatment
    • Sphingolipid Metabolism and Signaling
    • Lipid Membrane Structure and Behavior
    • Signaling Pathways in Disease

Papers in

    • Sphingolipid Metabolism and Signaling 40
    • Lipid Membrane Structure and Behavior 17
    • Steroid Chemistry and Biochemistry 12
    • Biochemical and Molecular Research 11
    • HIV/AIDS drug development and treatment 31

Andreas Billich

130 papers receiving 6.6k citations

Andreas Billich's Hit Papers

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis 2010 · 1.0k citations
1.0k0+5+10Years since publication2505007501000

Peers

Andreas Billich
Comparison fields: 5 of 145
  • Virology 574
  • Molecular Biology 4.6k
  • Pharmaceutical Science 347
  • Cell Biology 866
  • Immunology 1.1k
Replace Stefan Schütze with:
Stefan Schütze Germany
Yasuyuki Igarashi Japan
Ingrid Herr Germany
John David Dignam United States
Mark E. Goldman United States
Antonello Mai Italy
David A. Gewirtz United States
Jun Zhou China
Els Wagenaar Netherlands
Pankaj Seth India
Andreas Billich relative to Stefan Schütze Germany Stefan Schütze's profile →
Citations per field
00.5×6.4×
Stefan Schütze · 1×
Citations per year

Countries citing papers authored by Andreas Billich

Since Specialization
Citations

This map shows the geographic impact of Andreas Billich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Billich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Billich more than expected).

Fields of papers citing papers by Andreas Billich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Billich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Billich. The network helps show where Andreas Billich may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Billich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Billich Line = papers co-authored together Andreas Billich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Hit paper breakdown →
20101015
2 2001412
3 2003368
4 2009306
5 2007270
6 2005226
7 1994158
8 1995150
9 2003141
10 1997127
11 2010123
12 2005119
13 2002107
14 2013106
15 2006101
16 199591
17 200190
18 200089
19 200784
20 200483

About Andreas Billich

Andreas Billich is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Virology and Immunology, having authored 131 papers that have together received 6.8k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (40 papers), HIV/AIDS drug development and treatment (31 papers), HIV Research and Treatment (25 papers), Estrogen and related hormone effects (17 papers), Lipid Membrane Structure and Behavior (17 papers), Carbohydrate Chemistry and Synthesis (13 papers), Steroid Chemistry and Biochemistry (12 papers) and Biochemical and Molecular Research (11 papers). The work is most often cited by research in Virology (574 citations), Molecular Biology (4.6k citations), Pharmaceutical Science (347 citations), Cell Biology (866 citations) and Immunology (1.1k citations). Andreas Billich has collaborated with scholars based in Austria, Switzerland and Germany. Frequent co-authors include Thomas Baumruker, Frédéric Bornancin, Peter Nußbaumer, Volker Brinkmann, Josef G. Meingassner, Diana Mechtcheriakova, Nicole Urtz, Fritz P. Schmook, Robert Schmouder and Peter Heining. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, ChemMedChem and Expert Opinion on Therapeutic Patents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact